Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

29.49 -0.92 (-3.03%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
99 100 Next >
News headline image
Cathie Wood Bought This Stock After Its 27% Drop. Should You? ↗
This biotech company's promising pipeline could result in multibillion-dollar revenue. 
Via The Motley Fool
News headline image
Where Will Novavax Be in 5 Years? ↗
Its been a good year so far for the biotech, but how long can it keep the momentum going? 
Via The Motley Fool
News headline image
Moderna Stock Trading Lower On Dismal Guidance, Analysts Cuts Price Targets Noting Competitive Pressure From GSK, Pfizer ↗
Moderna cuts its 2024 sales forecast due to weaker demand for COVID-19 vaccines. Sales now expected between $3B-$3.5B, down from $4B. Analysts adjust price targets, citing competitive pressures from... 
Via Benzinga
News headline image
Stock Market Takes Bearish Turn; Apple, Microsoft, Meta, Amazon, AMD In Focus: Weekly Review ↗
Apple and Meta had strong results, while AI spending remains robust. 
Via Investor's Business Daily
Topics Artificial Intelligence
News headline image
Moderna's Ongoing Decline ↗
Another wipeout: this one, the lovely pharma opportunists at Moderna (MRNA), which has already lost 80% of its value. Just 20% to go! 
Via Talk Markets
News headline image
Moderna Reports Second Quarter 2024 Financial Results and Provides Business Updates
Via ACCESSWIRE
News headline image
Here's How Much You Would Have Made Owning Moderna Stock In The Last 5 Years ↗
 
Via Benzinga
News headline image
Cathie Wood's Ark Adds Over $19M Worth Of Moderna Shares After Thursday's 21% Plunge On Guidance Cut ↗
Moderna's vaccine magic is slowly losing its charm, as evidenced by the warning the company issued on Thursday but Ark reposed its faith in the company. 
Via Benzinga
News headline image
3 AI-Powered Healthcare Stocks Transforming Medicine ↗
Invest in AI healthcare stocks to benefit significantly from tech that could propel the healthcare market to $148.4 billion by 2029. 
Via InvestorPlace
Topics Artificial Intelligence
News headline image
US Stocks Close Lower As Apple, Amazon Report Earnings: Greed Index Moves To 'Fear' Zone ↗
The CNN Fear and Greed index fell to 39.6, signaling Fear in the market. Dow Jones dropped 495 points, Nasdaq down 2.3%, S&P 500 down 1.37%. 
Via Benzinga
Topics Stocks
News headline image
MRNA Investors Have Opportunity to Join Moderna, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
David Rubenstein Joins Moderna's Board of Directors
Via ACCESSWIRE
News headline image
Check Out What Whales Are Doing With MRNA ↗
 
Via Benzinga
News headline image
Decoding Moderna's Options Activity: What's the Big Picture? ↗
 
Via Benzinga
News headline image
Crude Oil Moves Lower; Moderna Shares Plunge ↗
 
Via Benzinga
News headline image
Stock Of The Day: Moderna Stock Plunges, Breaking Key Support Levels Following Earnings Report ↗
Shares of Moderna (MRNA) have broken an important support level. This means a new downtrend may be forming. 
Via Benzinga
News headline image
Moderna (MRNA) Q2 2024 Earnings Call Transcript ↗
MRNA earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Stocks To Watch Today: MRNA, META, And AMAT ↗
Meta Platforms surged on strong earnings and AI progress, while Moderna plummeted after slashing its sales outlook and Applied Materials saw its stock drop after being denied funding under the CHIPS... 
Via Talk Markets
Topics Artificial Intelligence
News headline image
Moderna CEO Stephane Bancel On Q2 Results, Slashing Its Full-Year Sales Guidance ↗
Moderna reported its latest quarterly earnings. 
Via Talk Markets
News headline image
Moderna Stock Sinks On Lowered 2024 Outlook, Cites Low European Sales, Competitive RSV Vaccine Market ↗
Moderna's stock drops after cutting 2024 sales forecast due to reduced COVID-19 vaccine demand. The company now expects net sales of $3-$3.5 billion. Q2 revenue hits $241 million, beating expectations,... 
Via Benzinga
News headline image
Moderna Slashes Its Outlook On 'Very Low' European Sales Despite Quarterly Beat ↗
Moderna delivered nearly double the sales analysts expected in the second quarter. 
Via Investor's Business Daily
News headline image
Get Your Money Out of These 3 Biotech Stocks Before the End of July ↗
These stocks are at a risk of providing negative returns to shareholders due to the several operational challenges faced by the companies. 
Via InvestorPlace
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Top Research Reports For Amazon.com, Prologis & Infosys ↗
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc., Prologis, Inc. and Infosys Limited, as well as a micro-cap stock Blue Dolphin Energy Company. 
Via Talk Markets
News headline image
3 Flying Car Stocks That Could Be Multibaggers in the Making: July Edition ↗
Discover three flying car stocks poised for significant growth. Explore key players and market insights in this comprehensive July edition. 
Via InvestorPlace
News headline image
COVID Activity Is Elevated Across 26 States In Summer Surge, Biden Remains In Isolation: 3 Vaccine Stocks To Watch ↗
Over half of US states have high levels of Covid-19 in wastewater as President Biden isolates with virus. New vaccines expected by Sept. 
Via Benzinga
News headline image
3 Biotech Stocks That Could Be Multibaggers in the Making: July Edition ↗
These biotech stocks have promising outlooks that will bring major fortune to investors. Buy before it is too late. 
Via InvestorPlace
News headline image
European Commission Faces Court Criticism Over COVID Vaccine Contract Transparency Ahead Of Vote on Ursula Von Der Leyen's Reappointment ↗
European Commission faces scrutiny over COVID vaccine contract transparency ahead of key vote. Legal challenges and implications discussed. 
Via Benzinga
News headline image
3 Biotech Stocks to Buy in Case of Another Pandemic ↗
These are three of the best biotech stocks to keep an eye on as the industry helps governments prepare for the next pandemic. 
Via InvestorPlace
News headline image
Moderna, Regeneron Pharmaceuticals And 2 Other Stocks Insiders Are Selling ↗
 
Via Benzinga
< Previous 1 2
...
28 29 30 31 32 33 34 35 36
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.